- Society for Maternal-Fetal Medicine Special Statement: Quality metrics for optimal timing of antenatal corticosteroid administrationSMFM, RF Hamm, CA Combs, P Aghajanian, AM Friedman, Patient Safety and Quality Committee — 2022Filed under: SMFM Statement
- Society for Maternal-Fetal Medicine Special Statement: Cognitive bias and medical error in obstetrics—challenges and opportunitiesSMFM, F Atallah, RF Hamm, CM Davidson, CA Combs, Patient Safety and Quality Committee — 2022Filed under: SMFM Statement
- Society for Maternal-Fetal Medicine Special Statement: Checklist for pregnancies resulting from in vitro fertilizationSMFM, RS Abu-Rustum, CA Combs, CM Davidson, AG Edlow, MA Kominiarek, P Rajan, S Ros, Patient Safety and Quality Committee, Patient Education Committee — 2022Filed under: SMFM Statement
- Clinical considerations for management of severe complications when abortion care is restrictedSMFM — 2022Filed under: SMFM Statement
- Society for Maternal-Fetal Medicine Statement: Antihypertensive therapy for mild chronic hypertension in pregnancy–The Chronic Hypertension and Pregnancy trialSMFM, Publications Committee — 2022Filed under: SMFM Statement
- Society for Maternal-Fetal Medicine Special Statement: Best-practice recommendations for ultrasound network connectivitySMFM, T Lee, J Stone, V Jain, N Avtalion, J Wickersham, J Haddock, M Scott, C Grone, D Hibbs, KS Gibson, H Feltovich, B Iriye, D Lagrew, Clinical Informatics Committee — 2022Filed under: SMFM Statement
- Society for Maternal-Fetal Medicine Consult Series #61: Anticoagulation in pregnant patients with cardiac diseaseSMFM, LD Pacheco, G Saade, V Shrivastava, R Shree, U Elkayam, Publications Committee — 2022Filed under: Internal Medicine & Medicine Subspecialists, OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist, Consult Series
- ACOG SMFM Obstetric Care Consensus #11: Pregnancy at age 35 years or olderACOG, SMFM, A Gantt, TD Metz, JA Kuller, JM Louis, AG Cahill, MA Turrentine — 2022Filed under: Obstetric Care Consensus (OCC)
- International Society for Prenatal Diagnosis Updated Position Statement on the use of genome-wide sequencing for prenatal diagnosisIB Van den Veyver, N Chandler, LE Wilkins-Haug, RJ Wapner, LS Chitty, Board of Directors — 2022Filed under: SMFM Endorsed Partner Publication
- ACOG Statement on FDA Warning on Genetic Non-Invasive Prenatal Screening Tests ACOG — 2022Filed under: SMFM Endorsed Partner Publication
